vimarsana.com

Page 18 - மருத்துவர் சங்கம் ஒன்றுபட்டது கிஂக்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sluggish Vaccinations Prompt Rising Dismay in Europe

English By Jamie Dettmer Share on Facebook Print this page The rollout of COVID vaccinations in Europe isn t going as smoothly as officials hoped, with critics saying governments didn t prepare sufficiently for the inevitable procurement and logistical challenges in what amounts to the biggest mass inoculation campaign ever seen.  A series of logistical missteps marred the first week of the European Union s vaccine strategy, say critics, prompting public frustration with the pace of inoculations. French President Emanuel Macron has castigated his own ministers for the painfully slow start of France s inoculation effort, which saw only 400 people receive their initial Pfizer-Biontech jab in the first week the program started.  

US surgeon general says Covid-19 projections are scary, but urges Americans to keep following precautions

US surgeon general says Covid-19 projections are scary, but urges Americans to keep following precautions US Surgeon General Jerome Adams speaks with CNN on Sunday, January 3. CNN US Surgeon General Jerome Adams called on the American people to continue to take Covid-19 precautions as cases surge following the Thanksgiving holiday, and the impacts of travel over the Christmas holiday continue to unfold. I want people to know the projections are pretty scary, but they are projections. What we do now matters. If you gathered over the holidays outside of your household without a mask, there are still measures you can take right now, Adams told CNN s Jake Tapper.

Batches of Oxford vaccine arrive at UK hospitals ahead of nationwide roll-out

Batches of Oxford vaccine arrive at UK hospitals ahead of nationwide roll-out Tom Gillespie, news reporter Replay Video UP NEXT Batches of the Oxford/AstraZeneca coronavirus vaccine have started arriving at UK hospitals ahead of the jab s nationwide roll-out. Some 530,000 doses of the treatment will be available for roll-out across the UK from Monday, with vulnerable groups already identified as the priority for immunisation. The vaccine has been developed in the UK by Oxford University and the pharmaceutical giant AstraZeneca. The roll-out will begin after England s chief medical officer Chris Whitty warned vaccine shortages are likely to cause problems for several months .

31Dec2020 Market Close: Wall Street Sets Records At The Closing Bell For 2020, DOW Up 197, SP 500 Closes Up +0 6%, Both Indexes Setting New Historic Highs, Nasdaq Closed Up 0 4%, Bitcoin Back Up To 29,152

Oil up despite another rig count increase (SPY +0.6%). Oil prices end 2020 on a positive note, but suffer 20% annual fall as pandemic took toll on demand. The Market in Perspective Here are the headlines moving the markets. Merger Mania Is Transforming Canadas Oil Scene Canadas oil landscape looks encouraging for 2021 as Whitecap Resources Inc. acquires two oil and gas companies in addition to mergers between other energy companies, with anticipated growth through the coming year as demand for energy steadily increases. In November, Whitecap Resources announced a plan to acquire rival company TORC Oil & Gas through an all-stock transaction of $704.12m equivalent. The deal is expected to go through by 25 February 2021, providing an encouraging outlook for the first quarter of next year. This merger

UK chief medical officers defend delay between Covid-19 vaccine doses

UK chief medical officers defend delay between Covid-19 vaccine doses CNN 1/1/2021 By Laura Smith-Spark and Nada Bashir, CNN © Frank Augstein/Pool/Getty Images A change to the UK s vaccination strategy has raised questions from experts The UK s chief medical officers have defended a decision to delay second doses of the Pfizer/BioNTech vaccine in order to prioritize first doses, saying it will protect as many vulnerable people as possible while the coronavirus is running rampant. The new strategy, announced Wednesday by the head of the UK s medicines regulator MHRA, means that the interval between doses could be extended to up to 12 weeks, instead of the three weeks previously stipulated.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.